EC Healthcare
UNHLF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $4,140 | $4,211 | $3,875 | $2,920 |
| % Growth | -1.7% | 8.7% | 32.7% | – |
| Cost of Goods Sold | $798 | $666 | $553 | $350 |
| Gross Profit | $3,342 | $3,545 | $3,322 | $2,570 |
| % Margin | 80.7% | 84.2% | 85.7% | 88% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $255 | $219 | $233 | $163 |
| SG&A Expenses | $432 | $426 | $405 | $302 |
| Sales & Mktg Exp. | $177 | $207 | $173 | $139 |
| Other Operating Expenses | $2,815 | $2,932 | -$36 | -$41 |
| Operating Expenses | $3,247 | $3,359 | $3,079 | $2,178 |
| Operating Income | $95 | $109 | $219 | $363 |
| % Margin | 2.3% | 2.6% | 5.6% | 12.4% |
| Other Income/Exp. Net | -$196 | -$92 | -$55 | -$10 |
| Pre-Tax Income | -$101 | $17 | $136 | $321 |
| Tax Expense | $11 | $1 | $29 | $51 |
| Net Income | -$167 | -$19 | $70 | $198 |
| % Margin | -4% | -0.4% | 1.8% | 6.8% |
| EPS | -0.14 | -0.016 | 0.059 | 0.17 |
| % Growth | -775% | -127.1% | -65.3% | – |
| EPS Diluted | -0.14 | -0.016 | 0.059 | 0.17 |
| Weighted Avg Shares Out | 1,185 | 1,185 | 1,181 | 1,153 |
| Weighted Avg Shares Out Dil | 1,185 | 1,185 | 1,184 | 1,173 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17 | $16 | $5 | $1 |
| Interest Expense | $89 | $101 | $64 | $49 |
| Depreciation & Amortization | $631 | $626 | $587 | $432 |
| EBITDA | $619 | $743 | $787 | $803 |
| % Margin | 15% | 17.7% | 20.3% | 27.5% |